Reference

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet . 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv . Published online February 9, 2020:2020.02.06.20020974. doi:10.1101/2020.02.06.20020974
3. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ . 2020;368. doi:10.1136/bmj.m606
4. Kuek A, Hazleman BL, Östör AJK. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: A medical revolution. Postgrad Med J . 2007;83(978):251-260. doi:10.1136/pgmj.2006.052688
5. Mauvais-Jarvis F. Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19. Diabetes . 2020;69(9):1857-1863. doi:10.2337/dbi19-0023
6. Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis . 2020;20(4):400-402. doi:10.1016/S1473-3099(20)30132-8
7. Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerg Microbes Infect . 2021;10(1):266-276. doi:10.1080/22221751.2021.1884503
8. Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.Autoimmun Rev . 2020;19(7):102567. doi:10.1016/j.autrev.2020.102567
9. Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines: Cytokine storm: The elements of rage! Open Biol . 2020;10(9). doi:10.1098/rsob.200160
10. Samir D. Oxidative Stress Associated with SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease - A Systematic Review.J Infect Dis Epidemiol . 2020;6(3). doi:10.23937/2474-3658/1510121